
Producing vaccines against viral threats is a potentially hazardous business and that’s why manufacturers have to operate strict controls to ensure that no pathogens escape.

Producing vaccines against viral threats is a potentially hazardous business and that’s why manufacturers have to operate strict controls to ensure that no pathogens escape.

“PLURIPOTENT” is a long word that means “able to do many things”. It is the technical term applied to stem cells that can generate many different sorts of bodily tissue, rather than just one sort, which is all that lesser stem cells can manage. But many researchers hope these cells will be pluripotent in other ways, too. Not only might they be used to make replacement tissues and organs for transplantation into those whose existing body parts no longer work properly (an approach known as regenerative medicine), they might also be used to produce pure cultures of cells for the early testing of drugs.
While researchers are busy identifying new biomarkers to detect disease and tailor treatments to individual needs, legal battles have been waged all the way up to the Supreme Court, trying to sort out whether a private company can own the rights to a particular biomarker.

5,000 people with asthma end up in the hospital each day. It’s a number that’s at least partially avoidable, since as many as 75% of patients are using their inhalers improperly.
The T-Haler, a prototype designed by Cambridge Consultants, is an inhaler that trains patients in using inhalers. Fitted with Wi-Fi and sensors, the T-Haler can sense how it’s being used and give real-time feedback on a computer screen. The design firm claims that, with just three minutes of training with the T-Haler, proper use of inhalers skyrockets from 20% to 60%.
Forget antibiotics, let’s try nanoparticles. That’s according to DARPA, the US military’s research arm, which says that rather than spend money on new antibiotics, which only work until bacterial strains grow resistant, “readily adaptable nanotherapeutics” can fight infection instead.
Is the emerging field of nanomedicine a breathtaking technological revolution that promises remarkable new ways of diagnosing and treating diseases? Or does it portend the release of dangerous nanoparticles, nanorobots or nanoelectronic devices that will wreak havoc in the body? A new review of more than 500 studies on the topic concludes that neither scenario is likely. It appears in ACS’ journal Molecular Pharmaceutics.